Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving

The country's first convalescent plasma transfusion trial results have been peer-reviewed and published, showing 19 out of 25 patients improving with the treatment and 11 discharged from the hospita...

Breakthrough Drug for Covid-19 May Be Risky for Mild Cases

Scientists in Britain announced a major breakthrough in the battle against the coronavirus last week, reporting they had found the first drug to reduce deaths among critically ill Covid-19 patients.

Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome

Severe cases of COVID-19 infection, often leading to death, have been associated with variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal stromal cells (MSCs) is ...

MSC Therapy for Acute Respiratory Distress Syndrome; It’s Time to Accelerate Clinical Trials for COVID-19 Patients in Need

A new systematic review and meta-analysis of clinical studies using mesenchymal stromal cells (MSCs) led by a team at the Mayo Clinic, and including researchers from Emory, Duke, Case-Western, and t...

coronavirus in middle east

Coronavirus stokes Middle East boiling points

The Middle East has many reasons to fear the coronavirus pandemic, but it has one big advantage when it comes to resisting it. Most people in the region are young.

Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19

In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospectiv...

Academy KOL: Mesenchymal Stem Cell Therapy for COVID-19 (Dr. Miguel Garber, Spain)

The immunomodulatory and anti-inflammatory properties of MSCs in the treatment of respiratory diseases were confirmed by more than 15 complete clinical studies, and more than 70 trials in this reg...

Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy In Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use

COVID-19 has affected the United States leading to a national emergency with health care and economic impact, propelling the country into a recession with disrupted lifestyles not seen in recent h...

COVID-19 in Europe: the Italian lesson

evere acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide,1 and WHO declared the coronavirus disease 2019 (COVID-19) outbreak a pandemic on March 11, 2020.

Choose language »